Development of a symptom assessment instrument for chronic hemodialysis patients: The dialysis symptom index
Development of a symptom assessment instrument for chronic hemodialysis patients: The dialysis symptom index
复制标题
DOI：
10.1016/j.jpainsymman.2003.07.004
复制
发表时间：
2004-03-01
影响因子：
4.7
通讯作者：
Switzer, GE
中科院分区：
文献类型：
--
作者：
Weisbord, SD;Fried, LF;Switzer, GE
由于缺乏有效的症状评估工具，对血液透析患者症状的患病率、严重程度或影响知之甚少。我们系统地开发了一个指数来评估这一患者群体中的身体和情感症状负担。我们采用了四个步骤来生成该指数：透析生活质量量表综述、三个焦点小组、专家内容效度评估和重测信度测量。发现了75种症状。其中，46个出现在大于或等于4个文书/重点小组中，并被考虑列入。12个项目被归入其他症状结构，专家判断其余4个项目不相关，新指数中剩下30个项目。总体kappa统计量为0.48+/-0.22。这些步骤使血液透析患者的30项症状评估指标得以系统地开发。在广泛使用之前，还需要进行额外的信度和效度测试。(C)2004年美国癌症疼痛缓解委员会。爱思唯尔公司出版，版权所有。
Little is known about the prevalence, severity, or impact of symptoms in hemodialysis patients because of the lack of a validated symptom assessment instrument. We systematically developed an index to assess physical and emotional symptom burden in this patient population. We employed four steps in the generation of this index: a review of dialysis quality-of-life instruments, three focus groups, experts' content validity assessment, and test-retest reliability measurement. Seventy-five symptoms were identified. Of these, 46 appeared in greater than or equal to 4 of the instruments/focus groups and were considered for inclusion. Twelve were grouped into other symptom constructs and experts judged four of the remaining items not to be pertinent, leaving 30 items in the new index. Overall kappa statistic was 0.48 +/- 0.22. These steps allowed the systematic development of a 30-item symptom assessment index for hemodialysis patients. Additional reliability and validity testing is needed prior to its widespread use. (C) 2004 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.